Breaking News
Get 50% Off 0
💎 Bargain Hunter: Undervalued stocks with massive upside potential
Get the list
Close

Umbra Companies Inc (UCIX)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Add to/Remove from a Portfolio Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
1.5800 +0.0000    +0.00%
05/08 - Closed. Currency in USD
Type:  Equity
Market:  United States
  • Volume: 0
  • Bid/Ask: 0.0000 / 0.0000
  • Day's Range: 1.5700 - 1.5800
Umbra Companies 1.5800 +0.0000 +0.00%

Umbra Companies Inc Company Profile

 
Get an in-depth profile of Umbra Companies Inc, including a general overview of the company's business and key management, as well as employee data and location and contact information.
IndustryReal Estate Operations
SectorReal Estate
Employees

23

Equity Type

ORD

Zeo ScientifiX, Inc., a clinical-stage biopharmaceutical company, focuses on the development of biological therapeutics for the treatment of degenerative diseases and regenerative medicines. The company’s lead product candidate is Zofin, an acellular biologic therapeutic derived from perinatal sources, which is in Phase I/II clinical trial to treat COVID-19, chronic obstructive pulmonary disease, and knee osteoarthritis. It also provides Patient Pure X, an autologous blood-derived biologic technology, that helps the body’s natural ability to decrease cellular inflammation and promote tissue healing. In addition, the company develops and distributes products that incorporate its proprietary ingredients for products to be used in topical aesthetic applications; ZEO GROW X, a professional-grade formula that delivers a concentrated dose of topical exosomes that help support follicular function; ZEO GROW BOOST; and EXO FOLLICLE FUEL. The company was formerly known as Organicell Regenerative Medicine, Inc. and changed its name to Zeo ScientifiX, Inc. in February 2024. Zeo ScientifiX, Inc. was incorporated in 2011 and is headquartered in Davie, Florida.

Contact Information

Address 3321 College Avenue Suite 246
Davie, 33314
United States
Phone 888 963 7881
Fax -

Top Executives

Name Age Since Title
Paul Francis Campion - - Member of Medical Advisory Board
Craig Laurence Ziering - - Member of Medical Advisory Board
Dan Sperling - - Member of Medical Advisory Board
Riley J. Williams - - Member of Medical Advisory Board
Juan Chavez - - Member of Medical Advisory Board
Tami Meraglia - - Member of Medical Advisory Board
Glenn M. Charles - - Member of Medical Advisory Board
Rolf Wallin - - Member of Medical Advisory Board
Josh Sandell - - Member of Medical Advisory Board
Chuck Bretz 66 2022 Independent Chairman of the Board
Harry Adelson - - Member of Medical Advisory Board
Henry C. Sobo - - Member of Medical Advisory Board
David M. Crane - - Member of Medical Advisory Board
Michale J. Barber - - Member of Medical Advisory Board
David C. Socol - - Member of Medical Advisory Board
Ian T. Bothwell 65 2016 Interim CEO, CFO & Director
Paul Thompson - - Member of Medical Advisory Board
Dennis J. Courtney - - Member of Medical Advisory Board
Bryan Kelly - - Member of Medical Advisory Board
Fernando Pinto - - Member of Medical Advisory Board
Matthew Burnett - - Member of Medical Advisory Board
Eugene Rajaratnam - - Member of Medical Advisory Board
Billy Ray Ledbetter - - Member of Medical Advisory Board
Julian Gershon - - Member of Medical Advisory Board
Stephanie M. Singer - - Member of Medical Advisory Board
Barry Joseph Kuttner - - Member of Medical Advisory Board
Carolyn DeLucia - - Member of Medical Advisory Board
Mark L. Gonzalgo - - Member of Medical Advisory Board
George C. Shapiro 63 2018 Chief Medical Officer & Director
William K. Kapp - - Member of Medical Advisory Board
Matthew Lief - - Member of Medical Advisory Board
Robert Neal Rouzier - - Member of Medical Advisory Board
Marianne La Barbera - - Member of Medical Advisory Board
Mark Zhuk - - Member of Medical Advisory Board
Alvaro J. Ocampo - - Member of Medical Advisory Board
Sonita Sadio - - Member of Medical Advisory Board
Bennett L. Willard - - Member of Medical Advisory Board
Mohammed Siddiqui - - Member of Medical Advisory Board
Robert Madda - - Member of Medical Advisory Board
Raymond Ishman - - Member of Medical Advisory Board
Mounir Wassef - - Member of Medical Advisory Board
Gerald S. Glauser 76 2022 Independent Director
Leathem S. Stearn 75 2022 Independent Director
Adam Rosoff - - Member of Medical Advisory Board
Joseph Frank Pizzolato - - Member of Medical Advisory Board
Damon M. Whitfield - - Member of Medical Advisory Board
Randolph Whipps - - Member of Medical Advisory Board
Mitchell B. Sheinkop - - Member of Medical Advisory Board
Gurvinder Pal Singh 63 2022 Independent Director
Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

UCIX Comments

Write your thoughts about Umbra Companies Inc
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Apple
Continue with Google
or
Sign up with Email